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Abstract
Is Supplemental Leucine Intake Associated with Enhanced Post Exercise Muscle Protein
Synthesis and Attenuated Muscle Protein Breakdown?
Knight AD, Benardot D, Thompson W, and Henes ST
Introduction: The role of individual amino acids on protein synthesis and their impact
on physical performance is of high importance to athletes and to those studying the
science of sports nutrition. Leucine, one of three branched-chain amino acids, is a
frequently researched amino acid because of its potential stimulatory effect on muscle
protein synthesis (MPS) following exercise in humans.
Purpose: Although there have been many studies conducted on leucine’s muscle
stimulatory effect, questions remain as to the efficacy and feasibility of leucine as an
MPS catalyst. Contributing to these questions are the widely varied dosing and timing
strategies that different researchers have employed. It is the purpose of this thesis,
therefore, to assess the differences in study protocols and shed light on the potential
effectiveness on leucine as a MPS stimulator. Central to this issue is whether
supplemental leucine intake is associated with enhanced post exercise MPS and, if so,
what associated factors, including timing and level of intake, are most likely to influence
this effect.
Methods: A comprehensive review of the literature on leucine and its effect on MPS was
performed. Studies were organized into similar topics, with an assessment and summary
of effect produced for each topic area. A general conclusion was made that was based on
the summary of each topic area.
Results: Leucine is involved in protein metabolism regulation through its role in
stimulating the mammalian target of rapamycin (mTOR) signaling cascade and by
indicating energy and amino acid availability. It functions to initiate MPS and decrease
muscle protein breakdown by downregulating the ubiquitin-proteasome system,
lysosomal activity, and/or increasing circulating insulin.
Conclusions: Supplementation with the amino acid leucine effectively enhances MPS
and attenuates muscle protein degradation in humans following bouts of physical
exertion. Leucine intake in amounts greater than that found in ~20g whole protein
saturates MPS and increases leucine oxidation. For this reason, an upper limit of leucine
intake should be established. While leucine successfully increases MPS, it remains
unclear whether this translates to enhanced physical performance, an area that requires
more studies to be conducted.
Key Words: Leucine, protein turnover, muscle protein synthesis, amino acid
supplementation
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Introduction
Improving physical performance is a goal for athletes and non-athletes alike. Thousands
of research studies have been conducted with this specific purpose in mind. One
noticeable contributor to enhanced performance is lean body mass (Reid et al., 2008). As
a result of these studies, the effect of diet and specific substrate and nutrient consumption
on muscle and lean body mass has become a highly researched field (Howald &
Decombaz, 1983; Tipton & Wolfe, 2004; Burke et al. 2006; Lambert et al. 2004). In the
course of this research, several possible ergogenic aids have been posited to enhance
performance in athletes. The essential amino acid leucine has been identified as a key
regulator in protein metabolism for over 30 years (Buse & Reid, 1975), but the
biochemical basis for its effect, and its other prominent roles in vivo are still being
examined at length (Norton & Layman, 2006; Roh et al. 2003; Li et al. 2011; Zanchi et
al. 2012). This review focuses on the role of leucine in protein metabolism, especially
synthesis, and its effects on several other contributors to physical performance.

Protein turnover occurs as muscle protein constantly changes and remodels by
synthesizing new proteins and breaking down existing proteins (Norton & Layman,
2006). Throughout a typical day, the ratios of protein synthesis to breakdown vary
significantly. Nutrients become available post-meal and protein synthesis and breakdown
both increase, but protein degradation occurs to a lesser extent, resulting in a net positive
1
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balance of protein turnover. During a prolonged period with no food consumption,
protein synthesis decreases by 15 to 30%, resulting in a net catabolic period. That period
of catabolism continues until adequate energy and amino acids are ingested to stimulate
protein synthesis (Norton & Layman, 2006). Both exercise and nutrition have been found
to strongly influence net muscle protein balance (Alvestrand et al., 1990; Morgan et al.,
1971; Rannels et al., 1974; Tipton et al., 2009). Protein metabolism in skeletal muscle
tissue is highly responsive to nutrient intake in healthy individuals and in addition to food
ingestion, exercise can effectively alter protein turnover, as it stimulates both protein
synthesis and protein breakdown (Biolo et al., 1995; Koopman et al., 2006). Protein
gains occur only as a result of positive net muscle protein over a given time period.
Positive net muscle protein balance results either from increased muscle protein synthesis
and/or decreased muscle protein degradation. For hypertrophy of muscle to take place,
muscle protein synthesis (MPS) must surpass muscle protein catabolism (Coburn et al.,
2006). Consumption of amino acids through protein ingestion or intravenous injection is
essential in accentuating post-exercise muscle protein synthesis. Contractile activity and
availability of nutrients are strong modulators of exercise-induced adaptive responses
(Moore et al., 2009; Wilkinson et al., 2008). Furthermore, lack of nutrient provision in
timely proximity to high-intensity exercise bouts is possibly detrimental for maintenance
or promotion of muscle mass (Coffey et al., 2011).

The metabolic roles for amino acids go beyond serving solely as building blocks for de
novo protein synthesis. They serve in many roles, but for the purposes of this discussion,
amino acids also stimulate secretion of insulin, glucagon, growth hormone and IGF-1

3
(Wilcox, 2005). Reports show that co-ingestion of a protein hydrolysate with or without
additional leucine with carbohydrate effectively increases the plasma insulin secretion in
several populations, including endurance-trained athletes (van Loon et al., 2000). The
complex mechanisms by which amino acids promote and/or enhance insulin secretion are
diverse and are not yet fully understood. Like glucose-mediated insulin secretion,
intracellular catabolism of the metabolizable amino acids increases availability of
substrate for the tricarboxylic acid cycle. In the absence of food intake, net muscle
protein balance will stay negative (Coburn et al., 2006). Therefore, muscle hypertrophy
only occurs when sufficient food is consumed during post-exercise recovery.
Carbohydrate ingestion post-exercise, on the other hand, increases circulating insulin
concentrations, thereby reducing protein breakdown, but does not increase muscle protein
synthesis rates per se.

Availability of amino acids has been shown to be an important factor in promoting net
protein synthesis (Coburn et al. 2006). Administration of protein/amino acids (>15g)
following resistance exercise effectively increases muscle protein rates (Koopman et al.,
2007). Aside from their role in protein synthesis, amino acids play a key regulatory role
as signaling molecules modulating muscle protein metabolism (Rennie, 2006). This is
one reason why individuals who wish to enhance lean tissue mass must consume protein
after exercising to gain a positive protein balance and capitalize on the muscle adaptive
response.
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Early studies showed that high concentrations of all amino acids stimulate protein
synthesis and inhibit protein breakdown, particularly in skeletal muscle and specifically,
the three branched-chain amino acids (BCAAs), leucine, valine, and isoleucine. One
reason may be due to the fact that the BCAAs are the only essential amino acids oxidized
primarily extrahepatically, and while most tissues can oxidize them, skeletal muscle is
thought to be the principal site of branched-chain amino acid catabolism because of its
mass (Buse & Reid, 1975; Ahlborg et al., 1974). Of the three BCAAs, leucine alone has
been seen as the most potent stimulator of protein synthesis and it has an oxidation rate
higher than that of isoleucine or valine (Buse & Reid, 1975; Garlick & Grant, 1988).
Leucine is an essential amino acid, meaning it cannot be synthesized de novo by humans,
and must be acquired in the diet or supplemented as in many of the studies examined
here. These early studies began the continuing series of investigations into leucine’s role
in tissue protein mass, its mechanism of action, and its potential significance in
enhancing muscle protein composition in healthy subjects or mediating muscle protein
loss in states of catabolism (Garlick, 2005). Sufficient evidence points to leucine’s
functions as a protein synthesis initiator, as a modulator of the insulin signal cascade, and
even as a donor of nitrogen for alanine and glutamine production in the muscle. (Odessey
et al., 1974; Preedy & Garlick, 1986; Garlick & Grant, 1988; Norton & Layman, 2006).

In this thesis, the efficacy of leucine as a promoter of MPS will be examined, as well as
its role in attenuating muscle protein breakdown (MPB). Leucine regulates protein
synthesis in skeletal muscle, but also in other tissue as well, including cardiac and
adipose tissue (Lynch et al., 2002; Roh et al., 2003; Suryawan et al., 2012). Whether or
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not the increases seen in protein synthesis translate to improvements in physical
performance or muscle hypertrophy remain to be seen.

The relationship between exercise and leucine intake is another point that has been
extensively researched, but remains debatable. Resistance exercise produces increases in
protein synthesis that manifest shortly after exercise and continue for up to 48 hours
(Phillips, 2004). Does leucine intake, supplemental or dietary, enhance this already
increased protein synthetic response?

Another question posed by many is in regard to the safety of individual amino acid
intake. It has long been recommended that dosing of solo AAs is unnecessary and
potentially harmful. If this is the case with leucine, should only dietary sources be
recommended? The dose threshold of leucine and other EAAs is not clear, and neither is
the efficacy of leucine in conjunction with other substrates, dietary or not. Studies have
shown that elevations in serum EAAs were responsible for increases in muscle protein
synthesis independent of insulin or IGF-1 changes (Cuthbertson et al., 2004). Larger
doses of leucine have been shown to be significantly more effective at stimulating muscle
protein responses than doses equivalent to the average dietary intake of leucine (Glynn,
2010). Also, leucine levels must be adequately high to function in signaling and
metabolic roles since structural roles must be satisfied a priori, and leucine’s capacity to
signal and function as an oxidative substrate is based on sufficient intracellular
concentration (Li et al., 2011). Most potential advocates for leucine supplementation will
require a specific, numeric dose-response threshold.
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Assuming an appropriate dose based on controlled therapeutic studies is reached, timing
and length of supplementation is still necessary for initiation of therapy in any individual.
Since it is well established that metabolic pathway thresholds are overwhelmed by bolus
doses greater than ~20-25g protein and equivalent AA intake, leucine intake in bolus
doses greater than these equivalents are not recommended (Moore et al., 2009;
Churchward-Venne et al., 2012). Timing throughout a 24-hour period and in relationship
to exercise and periods of inactivity are equally important (Adechian et al. 2012). Few
studies have assessed the effects of long term supplementation, but initial results have
indications for human consumption.

One major factor that influences physical performance is not muscle hypertrophy or
physical endurance and strength, but mental stamina (Portier et al., 2008). It is apparent
that causes of fatigue are multifactorial, influenced by operations occurring in the
periphery and the central nervous system. This idea is posited in the central fatigue theory
which suggests that the onset of fatigue in prolonged exercise can be attributed to
changes in serotonin, dopamine, and noradrenaline concentrations. The synthesis of these
chemicals is largely dependent on AAs that use the same transporter through the bloodbrain barrier as the BCAAs, meaning that the plasma concentration ratio of these AAs is
a significant indicator of neurotransmitter synthesis (Meeusen & Watson, 2007). Leucine
in elevated concentrations may stymie these processes contributing to fatigue.

Many studies have been designed to study leucine and its potential attenuating effect on
sarcopenic muscle have potential indications for older athletes and those in which muscle
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wasting from disease are a concern. Data indicate that aging leads to a diminished muscle
protein accretion after EAA ingestion (Katsanos et al., 2006). Aging is associated with a
blunted response to EAA intake and thus, the effects of leucine on MPS. Other studies
have shown leucine supplementation increases the potential for muscle protein synthesis
in older adults and may supplement an otherwise insufficient or poor quality of dietary
protein more biologically available for muscle tissue growth and repair (Casperson et al.,
2012).

Despite its popularity over the years as a potential muscle enhancer and the multitude of
studies performed, the efficacy of leucine is still controversial. One reason for the lack of
consensus is the variability of methods utilized in these studies, and the inability to
generalize research results across the board. Investigation methods vary on dose
administered, additional substrates co-administered, timing prior to or following exercise,
length of supplementation, length of exercise, type of exercise, subjects tested, route of
administration, etc. Study results from different metabolites of leucine, like
hydroxymethylbutyrate (HMB), cannot be generalized to leucine as they only account for
only 5–10% of the metabolites produced from the degradation of leucine (Van Koevering
& Nissen, 1992). For these reasons, the question of whether supplemental leucine intake
is associated with enhanced post exercise muscle protein synthesis remains unclear.

Hypotheses
Hypothesis 1: Leucine stimulates muscle protein synthesis significantly more than other
amino acids.
Null Hypothesis 1: Leucine does not stimulate muscle protein synthesis
significantly more than other amino acids.

Hypothesis 2: Leucine attenuates muscle protein degradation following resistance
exercise.
Null Hypothesis 2: Leucine does not attenuate muscle protein degradation
following resistance exercise.

Hypothesis 3: Leucine intake enhances physical performance.
Null Hypothesis 3: Leucine does not enhance physical performance.
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Review of Literature
Leucine and Muscle Protein Synthesis
One of the very first studies to specifically look at leucine as a possible muscle protein
metabolism regulator was published in 1975. Buse and Reid (1975) hypothesized that at
least one of the three branched chain amino acids (BCAAs) was rapidly oxidized and its
stores in muscle cells depleted, serving as a catabolic signal. They surmised that leucine
acts as a regulator of protein turnover through its depletion and/or through its presence.

The study utilized incorporation of radiolabeled precursors into muscle proteins. A
compound of the BCAAs stimulated the incorporation of lysine into proteins. When
tested independently, valine was ineffective, isoleucine was inhibitory, but leucine
increased the specific activity of muscle proteins with or without the introduction of
insulin. Preincubation with leucine improved the specific activity of muscle proteins and
preincubation with other amino acids did not exhibit this same effect. The lysine
concentration in the tissue water decreased during incubation with leucine, signifying that
leucine also inhibited protein breakdown. During incubation with tyrosine the addition of
leucine increased the specific activity of muscle proteins, while the specific activity of
intracellular tyrosine remained constant and its concentration decreased, suggesting that
leucine also promoted protein synthesis.

9
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Researchers concluded that the muscle cell concentration of leucine may play a role in
regulating muscle protein metabolism and influence the transition to negative nitrogen
balance during fasting, uncontrolled diabetes, and the posttraumatic state. Leucine may
play a pivotal role in the protein-sparing effect of amino acids. Despite the encouraging
findings, authors of this study closed by adding the following caveat:
“…studies of the potential protein anabolic effect of leucine…would have to take
into account the possible deleterious effects that amino acid imbalance or
antagonism may produce in vivo” (Buse & Reid, 1975).
This early warning is especially applicable today in our world of over-supplementation
and amino acid mega-dosing.

Similar early studies demonstrated that high concentrations of amino acids stimulated
protein synthesis and inhibited protein degradation, particularly in skeletal muscle, but
also in cardiac muscle (May & Buse, 1989). Specifically, it was shown in heart muscle
that the stimulation by amino acids could be reproduced with only the three BCAAs, and
as seen in the isolated diaphragm muscle, leucine alone stimulated protein synthesis.
They found that net uptake of BCAAs was observed suggesting that these AAs were
utilized as an oxidative substrate and the increased rate of protein anabolism was due to a
direct effect on the protein synthesis pathway rather than an indirect effect from simply
increasing energy levels in the cell. Li and Jefferson (1978) found when they omitted
BCAAs from an AA mixture infused in rat skeletal muscle, the remaining AAs, even at
five times their normal plasma levels, had no effect on protein turnover. Another study
demonstrated that the ratio of individual BCAAs to the amount of leucine was more
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critical to nitrogen-sparing than the total percentage of BCAAs infused (Bonau et al.,
1984). Leucine intravenously infused during a prolonged fasting state resulted in
decreased plasma amino acid levels, nitrogen balance improvement and no difference in
excretion of 3-methylhistidine, which was found to suggest muscle protein synthesis
stimulation (Sherwin, 1978). This group of studies began a series of investigations into
leucine’s role in protein mass regulation and its mechanism of action (Morgan et al.,
1971; Rannels et al., 1974; Li & Jefferson, 1978).

Table 1: Summary of studies related to effect of mixed AA supplementation on muscle
protein synthesis
Reference
Population
Design
Findings
Morgan et al. Rats
Protein synthesis was
Protein synthesis
(1971)
measured using
increased when AA levels
incorporation of 14Cincreased from 1-5 times
phenylalanine into
normal levels.
heart protein.
Buse & Reid
Rats
Muscle proteins were
Leucine alone increased
(1975)
incubated in BCAAs
protein specific activity
and tracer
and increased MPS to the
incorporation was
greatest extent.
observed.
Li & Jefferson Rats
Fasted rats were
MPS was stimulated to a
(1978)
infused with BCAAs.
greater degree than rats
infused with an AA
mixture without BCAAs.
Bonau et al.
25 postDifferent
The high leucine group
(1984)
operative
concentrations of
had greater nitrogen
males with
BCAA IV solutions
balance and less muscle
bladder cancer. were administered for 7 catabolism.
days.
Preedy &
Rats
Fasted rats were refed
MPS was suppressed by
by intragastric or IV
anti-insulin injection.
Garlick (1986)
infusion of an AA plus
glucose mixture.
BCAAs increased MPS
Garlick &
Rats
AA and insulin
Grant (1988)
mixtures were given
over insulin infusion or
between meals.
non-BCAAs.
Louard et al.
10 humans
BCAAs were infused
MPB was suppressed, but
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(1990)
Schena et al.
(1992)

intravenously.
MPS was not increased.
16 humans
Participants trekked 21 BCAA supplementation
days at high altitude
increased MPS during
and took either BCAA chronic hypobaric
or placebo
hypoxia.
supplements.
Blomstrand et Humans
BCAAs were given to
BCAAs stimulated the
al. (2006)
subjects after resistance signaling pathways that
exercise.
control MPS.
Coffey et al.
8 healthy
Participants performed Nutrient provision
(2011)
young males
sprint cycling after
(including leucine)
ingesting nutrients or
increased anabolic
placebo.
signaling and MPS.
AA: Amino Acids; BCAAs: Branched Chain Amino Acids; MPS: Muscle Protein
Synthesis; IV: Intravenous; MPB: Muscle Protein Breakdown

In the studies performed with mixed AAs or BCAAs (Table 1), there was consensus that
MPS was stimulated. Most studies found that BCAAs increased MPS to a greater degree
than mixed AAs, or by using less substrate. One study listed in Table 1 did not see
increased MPS (Louard et al., 1990), but MPB was attenuated by BCAA infusion. Under
many different types of conditions, and in both rat and human populations, MPS was
stimulated by BCAA intake.

Early work produced considerable advances in the comprehension of the signal
transduction pathways involved in the control of muscle protein synthesis by amino acids
and insulin. The physiological role of leucine is then to act in combination with insulin to
activate the “switch” that stimulates muscle protein synthesis when availability of energy
and amino acids from food is signaled (Preedy & Garlick, 1986). The advantage of this
mode of regulation is that the switch calls for both amino acids, namely leucine, and
insulin to be present concurrently, so is only activated in ideal conditions (Preedy &
Garlick, 1986; Balage et al., 2011). Also contributing to the evidence for leucine’s

13
efficacy, when compared with glucose infusion, protein synthesis was stimulated equally
by a complete mixture of AAs, by only EAAs, and by only the BCAAs (Garlick & Grant,
1988). This demonstrates that specifically the BCAAs enhance insulin sensitivity of
muscle protein synthesis pathways.

An early study specifically demonstrated the ability of orally administered leucine to
stimulate recovery of skeletal muscle protein synthesis after exercise (Anthony et al.,
1999). Rather than simply providing post-exercise substrate, this study showed that
leucine alone was effective since feeding carbohydrate alone did not increase protein
synthesis rates above those of rats fasting post-exercise. Plasma insulin was elevated
similarly in rats fed either the macronutrient-mixed meal or the carbohydrate meal,
demonstrating that insulin acts together with another factor of the mixed meal to
stimulate protein synthesis. The authors posited that the inability of researchers in
previous animal studies to demonstrate that leucine stimulates skeletal muscle protein
synthesis was due to an inadequate leucine quantity administered to the animals. A higher
dose than previous was chosen in this study to maximize the effects of leucine. The
findings here suggest leucine stimulation of muscle protein synthesis is dose dependent
(Anthony et al., 1999).

Oral administration of a bolus amount of leucine equivalent to the daily intake (1.35g/kg
body weight) has been found to enhance skeletal muscle protein synthesis in studies with
food-deprived rats (Crozier et al., 2005). The dose of leucine used in previous studies is
quite large, equal to what is consumed in a 24-hour period by rats when allowed free
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access to standard lab chow. Since leucine is relatively insoluble, such a large dose may
not be generalizable to human studies. But this study was able to demonstrate that smaller
doses of leucine administered orally were successful in stimulating muscle protein
synthesis as well (Crozier et al., 2005).

Plasma leucine concentrations significantly increased in rats fed one meal each day that
contained proteins (i.e., β-lactoglobulin) high in leucine. As a result, MPS significantly
improved in these rats fed a leucine-rich diet. And most notably, the increased MPS
effect was maintained even after the 30-day supplementation. Additional studies are
needed to determine the length of supplementation that would produce a significant gain
in muscle protein (Rieu et al., 2007).

Another recent study showed that whey protein doses in insufficient quantities to
maximally effect muscle protein synthesis (Moore et al., 2009), supplemented with
leucine resulted in an increase in rates of MPS equal to those usually seen following 25g
whey protein doses. However, contrary to the authors’ hypothesis, supplementation of a
low dose whey protein with an EAA mixture absent of leucine also resulted in
stimulation of MPS no different from what was seen in the leucine-supplemented whey
protein. These findings contradict the hypothesis that MPS stimulation is directly
proportional only to the rise in leucine in the blood. The investigators postulated that
while leucine is potently able to stimulate MPS, only a small amount (~0.75g) is
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necessary to maximally stimulate MPS given that other EAAs are present in sufficient
quantities (~8.5g) (Churchward-Venne et al., 2012).

One study that examined the physiological mechanism of leucine efficacy identified
messenger RNA translation via the activation of a variety of intracellular signaling
proteins, especially those of the mTOR signaling cascade as the primary level of
regulation of acute muscle protein synthesis. Stimulation of muscle protein synthesis
after food intake or resistance exercise is accompanied by increased phosphorylation, and
activity, of the mTOR signaling pathway, and thus, protein synthesis. This biochemical
pathway has been identified in several studies as a possible mechanism by which leucine
increases MPS (Blomstrand et al., 2006; Casperson et al., 2012; Coffey et al., 2011;
Dreyer et al., 2008; Li, 2011). This study examined the response of protein synthesis and
total body leucine oxidation to increasing protein intake after an acute bout of resistance
exercise. Increasing protein intake stimulated muscle and plasma albumin protein
synthesis in a dose-dependent manner up to 20g dietary protein, after which there was a
significant stimulation of whole-body leucine oxidation and no added increase in protein
synthesis (Moore et al., 2009).

Other studies have not seen the efficacy of leucine as described by the aforementioned
researchers. Some saw no difference between the effects of leucine alone and all EAAs
(Bohé et al., 2003; Smith et al., 1992,1998; May & Buse, 1989); while others failed to see
the purported protein synthetic effects of leucine administration in vivo (McNurlan et al.,
1982; Louard et al., 1990).
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Table 2: Summary of studies related to the effect of leucine supplementation on
muscle protein synthesis
Reference
Population
Design
Findings
Buse & Reid
Rats
AA mixture added to
Leucine stimulated
(1975)
media to stimulate
protein synthesis, and
incorporation of lysine
mixtures without leucine
into proteins.
did not.
Sherwin (1978) Obese and
Leucine was given
Leucine infusion
Non-obese
intravenously between
stimulated MPS and
humans.
meals and after fasting.
attenuated MPB.
McNurlan et al. Rats
Leucine was
Leucine had no effect on
(1982)
administered to rats that MPS in any tissues.
were either fed, starved,
or protein-deprived.
Smith et al.
7 males
Participants received a
Synthesis rates were
(1992)
constant infusion of
higher after flooding,
valine and a flooding
regardless of the
dose of leucine
precursor chosen.
intravenously.
Smith et al.
23 young
Flooding doses of EAAs Flooding with EAAs
(1998)
males
were given and effects
increased tracer
on tracers were
incorporation.
observed.
Anthony et al.
Rats
Rats were divided into
Leucine stimulated MPS
(1999)
groups by exercise and
following exercise,
diet.
independent of plasma
insulin.
Crozier et al.
Rats
Fasted rats were given
Leucine stimulated MPS.
(2005)
bolus doses of oral
leucine.
Rieu et al.
Rats
Aging rats were fed
The leucine-rich diet
(2007)
diets with differing
stimulated MPS more
amounts of leucine
than others & maintained
content.
the effect >30 days.
Dreyer et al.
16 males
Participants ingested
Enhanced signaling
(2008)
either placebo or
increased MPS after the
leucine-enriched
leucine-enriched solution
solution after resistance was consumed.
exercise.
Moore et al.
6 young
Participants consumed
20g protein was sufficient
(2009)
males
differing amounts of
to maximally stimulate
protein after resistance
MPS. Excess intake led
exercise.
to oxidation.
Churchward24 males
Participants consumed
Low doses of whey with
differing amounts of
added leucine stimulated
Venne et al.
(2012)
whey with or without
MPS to the same degree
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Casperson et al.
(2012)

Older
humans

added leucine after
resistance exercise.
Meals were
supplemented with
leucine for 2 weeks.

as larger whey doses.

Increased stimulation of
the signaling pathways
that control MPS was
seen.
AA: Amino Acids; MPS: Muscle Protein Synthesis; MPB: Muscle Protein Breakdown;
EAAs: Essential Amino Acids

In these studies, performed to assess the effect of leucine intake on MPS, the consensus
was that increased stimulation of MPS was seen after leucine supplementation. The
majority of these studies found that leucine increased MPS to a greater degree than a
control or a similar mixture containing less leucine. Three studies of those examined here
did not see increased MPS, or saw the same effects induced by other EAAs. In
conclusion, it has been shown that under many different types of conditions, and in both
rat and human populations, MPS is stimulated by leucine intake or infusion.

Leucine and Muscle Protein Degradation
Carbohydrate and protein/amino acid ingestion during exercise recovery is part of an
effective strategy to stimulate muscle protein synthesis, inhibit protein breakdown and, as
a result, to augment net muscle protein accretion (Norton & Layman, 2006). Protein
catabolism is stimulated to a greater extent than protein synthesis following exhaustive
exercise, interestingly enough. Consequently, athletes need to consume sources of protein
post-exercise to achieve a positive protein balance and maximize their skeletal muscle
adaptive response (Koopman et al., 2007). While protein synthesis has been the focus of
countless studies involving leucine (Casperson et al., 2012; Coffey et al., 2011;
McNurlan et al., 1982; Pasiakos et al. 2011), protein degradation has not been a specific
area of concentration. Nagasawa et al. (2002) found that postprandial protein degradation
suppression was primarily due to amino acids, specifically leucine. Since muscle
hypertrophy occurs as a result of either increased protein synthesis or decreased protein
breakdown, leucine’s effect on protein degradation is of great interest.

Several studies have examined the effect of leucine supplementation on muscle protein
breakdown and post-exercise muscle recovery. One study evaluated the impact of BCAA
supplementation in adult hikers during a 21-day trek at high altitudes. They concluded
that BCAA supplementation may prevent muscle loss during the chronic hypobaric
hypoxemic conditions (Schena et al., 1992). The anabolic effect of leucine has been
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attributed to its inhibition of protein degradation by Nair et al. (1992), but interestingly,
they found no evidence that leucine stimulated muscle or whole body protein synthesis.

Baptista et al. (2010) attempted to elucidate the mechanisms behind leucine’s suppression
of protein catabolism found leucine supplementation attenuates muscle wasting by
downregulating the ubiquitin-proteasome system (UPS), which drives protein
degradation. The authors noted, however, that leucine supplementation did not restore
decreased protein synthesis that followed immobilization of rats in this study. This
suggests the protective effect seen in leucine supplementation is mediated by
downregulation of UPS gene expression, and not stimulation of protein synthesis. The
authors posit that leucine may be utilized as a therapeutic supplement for those faced with
long periods of immobilization following surgery, such as joint reconstruction.
In contrast, Sugawara et al. (2009) showed that leucine feeding in a protein deprived state
minimized protein catabolism. They suggested that downregulation of activity of the
lysosomal pathway, rather than UPS, is responsible for the muscle wasting attenuation
seen in rats with a leucine-rich diet. In addition, the study showed protein degradation
was significantly suppressed and muscle protein synthesis was not enhanced. This
suggests that instead of protein synthesis, reduction in muscle is inhibited by leucine and
regulated by protein degradation. When dietary protein is scarce, since amino acids are
used as material to synthesize muscle protein, substrate for muscle synthesis is also
deficient. The amount of amino acids supplied by muscle protein breakdown may not be
sufficient for protein synthesis. In contrast, material is not necessary for the suppression
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of protein degradation. According to the findings in these studies, muscle protein
degradation is a key factor in regulation of muscle turnover (Sugawara et al., 2009).

One explanation for leucine’s observed ability to abate MPB is in its stimulation of
plasma insulin. A higher leucine concentration than that typical of high-quality proteins
was found to produce transient decreases in MPB and enhance mTORC1 signaling,
which may induce protein synthesis in muscle (Dreyer, 2008; Li et al., 2011). However,
the observed changes did not translate into significant improvements in overall muscle
protein balance. Leucine in bolus doses, like many nutrients, causes an increase in
circulating insulin. Since insulin decreases MPB (Louard et al., 1992), the insulin
response in the leucine supplemented group may have contributed to the observed
decreases in MPB (Glynn et al., 2010). Another study found administration of leucine
suppressed protein degradation even without insulin action, to which this effect can often
be attributed (Nagasawa et al., 2002).

Another study found that high doses of supplemental leucine (>20g) did not to prevent an
increase in muscle damage biochemical markers following eccentric-based resistance
exercise, but that supplementation may have aided in the maintenance of force output
(Kirby et al., 2012). Another study researched the isolated effects of leucine added to a
carbohydrate beverage on recovery from resistance exercise. Biochemical markers of
muscle damage like creatine kinase (CK) and LDH, as well as athletes’ perception of
delayed onset muscle soreness (DOMS) and leucine’s possible attenuation of these was
examined. Researchers found that there were no significant differences in CK, LDH,
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DOMS, and number of squat repetitions in subjects who consumed pre- and post-exercise
carbohydrate beverages with or without leucine. The addition of 45 mg/kg leucine to
carbohydrate beverages did not attenuate blood markers of exercise-induced muscle
damage or participants’ perception of DOMS (Stock et al., 2010).

Decreases in protein synthesis and/or increases in protein degradation also occur during
tumor development. These changes induce skeletal muscle loss, fatigue, weakness, and
atrophy. While physical exercise can be an effective part of the rehabilitation of cancer
patients, any compounded effects from leucine on decreased MPB are significant. The
promising effects of leucine supplementation give rise to interest in leucine’s use for
individuals in catabolic disease states. Results in rats show that exercise and/or leucinesupplementation led to an improvement in lean body mass due to attenuation of protein
breakdown, maintenance of total muscle protein content, and increase in the muscle
myosin content (Salomão et al., 2010).

Table 3: Summary of studies related to effect of leucine supplementation on muscle
protein breakdown
Reference
Population
Design
Findings
Schena et al. 16 humans Participants trekked 21 days BCAA supplementation
(1992)
at high altitude and took
decreased muscle loss
either BCAA or placebo
during chronic
supplements.
hypobaric hypoxia.
Nair et al.
6 healthy
Leucine or saline was
Leucine decreased
(1992)
males
infused intravenously.
MPB across several
muscle sites.
Nagasawa et Rats
Rats were fed diets with
Leucine was able to
al. (2002)
differing protein
decrease the rate of
compositions or a leucine
MPB.
diet.
Koopman et 8 elderly
Crossover design where
Coingestion of leucine
al. (2007)
males
participants consumed a
did not attenuate MPB.
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control diet or one
supplemented with leucine
after exercise.
Rats were fed a protein-free
diet for 7 days and
supplemented with leucine.
Rats were supplemented
with leucine during hind
limb immobilization.

Sugawara et
al. (2009)

Rats

Baptista et
al.(2010)

Rats

Glynn et al.
(2010)

14 humans

Participants consumed
EAAs with normal or high
leucine content.

Stock et al.
(2010)

20 trained
humans

Salomão et
al. (2010)

Tumorbearing rats

Kirby et al.
(2012)

27 males

Participants performed
resistance exercise and
consumed a leucine
supplemented beverage
before and after.
Rats were divided into
groups and performed
exercise or did not, and
consumed a leucine-rich
diet or did not.
Participants performed drop
jumps and consumed a
placebo, leucine, or nothing.
Participants performed high
intensity endurance exercise
and subsequently ingested
leucine/protein supplement
or control.

Leucine
supplementation
inhibited MPB.
Leucine
supplementation
inhibited muscle
wasting.
Leucine
supplementation
showed a modest
decrease in MPB.
Leucine
supplementation did not
attenuate MPB.

Leucine, in
coordination with
exercise, decreased
MPB.

Leucine
supplementation did not
attenuate MPB.
Nelson et al. 12 males
The high leucine dose
(2012)
in the supplement
saturated BCAA
metabolism, increased
leucine oxidation and
attenuated MPB.
BCAA: Branched Chain Amino Acids; MPB: Muscle Protein Breakdown; EAAs:
Essential Amino Acids

In the studies (see Table 3) performed to assess the effect of leucine supplementation on
MPB, the consensus was that attenuation of MPB was observed. Most studies found that
leucine ingestion inhibited MPB to a greater degree than a control or a similar mixture
containing less leucine. The studies where leucine supplementation was seen to be
effective utilized long-term ingestion, or were consumed in conjunction with exercise.
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Three studies (Koopman et al., 2007; Stock et al., 2010; Kirby et al., 2012) of those
examined here (Table 3) did not see decreased MPB. Interestingly, all three of those
studies focused on the ability of leucine to decrease MPB through ingestion postexercise. In conclusion, it has been shown that under many different types of conditions,
and in both rat and human populations, MPB can be attenuated by leucine intake or
infusion.

Dietary versus Supplemental Intake
In the world of nutrition and exercise, the notion that “if a little is good, a lot is great” has
been long held. For this reason, the use of supplements and megadoses of many nutrients
has skyrocketed in recent years. Many individuals consider their diets healthy, but want
to enhance muscle synthesis and think supplementation may be the correct route.
Previous studies have utilized both dietary and supplemental sources of leucine, but none
have directly compared the two sources. Beyond the obvious question of safety, the
question begs, is this practice necessary to achieve desired results?

The concept of ingesting an isolated AA to stimulate MPS in the absence of an
abundance of other AAs is not new. However, since protein is comprised of multiple
AAs, a homogenous AA substrate would be unable to build muscle in the absence of
another AA source. If leucine were able to independently stimulate MPS, substrate would
be drawn from the intracellular AA pool. If there is sufficient delivery of AAs, synthesis
should continue. However, in vivo, intramuscular AA concentrations fall as seen in
studies on the effects of leucine infusion on human muscle (Alvestrand et al., 1990).
After initial stimulation of anabolism, the concentration of all other AAs fell and leucine
oxidation rose, likely because complete proteins could no longer be synthesized
(Alvestrand et al.,1990). Leucine-rich amino acid mixtures are more effective than
leucine alone at improving muscle mass and performance, suggesting the efficacy of
leucine is dependent on the presence of other amino acids (Balage et al., 2011; Preedy &
24
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Garlick, 1986). Likewise, Glynn et al. (2010) found no differences in MPS despite
significantly higher extracellular concentrations of leucine in one study.
If the biggest factor affecting MPS is AA availability, then dietary intakes of protein
should serve to provide adequate substrate for ongoing muscle synthesis. One study
specifically assessed the impact of leucine derived from complete meals on MPS
stimulation. Rats were fed diets of differing protein content from either wheat or whey
sources. Given equal protein intakes, whey protein increased MPS by as much as 52%
more than wheat protein. The authors concluded that postprandial mTOR signaling and
MPS stimulation is primarily directed by leucine, but the response duration is influenced
by additional factors (Norton et al., 2009).

Other studies have shown MPS becomes saturated when blood EAAs rise above 50-80%
greater than the fasted state (Alvestrand et al., 1990). Observers found that the
concentration of serum urea increased dramatically at high rates of AA infusion, due to
the increase of hepatic catabolism of AAs delivered in excess of bodily ability to utilize
them for muscle (Bohé et al., 2003). Others have agreed that there is little evidence that
moderate physical activity increases protein requirements beyond those achieved by
eating a normal diet that satisfies daily nutrient requirements (Rennie et al., 2006; Glynn
et al., 2010). Provision of exogenous BCAAs may stimulate MPS but the effect is likely
to be transitory given the “muscle-full” phenomenon already mentioned (Rennie et al.,
2006).
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In contrast, some studies suggest leucine supplementation may improve muscle protein
synthesis in response to lower protein meals (Casperson et al., 2012; Churchward-Venne
et al., 2012). Following exercise, a suboptimal dose of protein high in leucine content or a
mixed nutrient meal supplemented with leucine enhances MPS (Rieu et al., 2003;
Churchward-Venne et al., 2012). Casperson et al. (2012) found that supplementing the
daily meals of older adults for two weeks with 4g leucine increased FSR and anabolic
signaling.

The evidence from these studies suggests consumption of free leucine versus a dietary
protein leads to an imbalance between leucine signaling and AA availability. This
discrepancy in the initiation of MPS signaling pathways and delayed, or deficient,
availability of AAs as substrates may even explain why MPS is stimulated for a short
duration in many of these studies and did not convert to significant muscle accretion
(Dardevet et al., 2012)

Table 4: Summary of studies related to dietary intake of leucine or supplementation
Reference
Population
Design
Findings
Alvestrand et
12 females
Participants were infused Plasma and intracellular
al. (1990)
with leucine
levels of AAs decreased,
intravenously.
and 40% of excess
leucine was oxidized.
Bohe et al.
21 humans
Participants were infused MPS became saturated at
(2003)
with mixed AAs at a rate high concentrations of
240% above basal levels. intramuscular EAAs.
Rennie et al.
Humans
Participants were infused Leucine stimulated MPS
(2006)
with mixed AAs or
to the same extent as
leucine.
complete meals.
Norton et al.
Rats
Rats consumed diets with Higher leucine content of
(2009)
differing leucine content. meals correlated to peak
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Glynn et al.
(2010)

14 humans

activation of MPS.
Leucine content in 10g
EAAs is sufficient to
maximize MPS.

Participants consumed
EAAs or EAAs with
increased leucine
content.
Casperson et al. 8 older
Meals were
Leucine improved MPS
(2012)
humans
supplemented with
in response to lower
leucine for 2 weeks.
protein meals.
Churchward24 males
Participants completed
Low doses of whey
Venne et al.
resistance exercise and
supplemented with
(2012)
consumed varying doses leucine or EAAs
of whey supplemented
stimulated MPS to the
with leucine or EAAs
same degree as larger
without leucine.
doses.
Nelson et al.
12 males
Participants performed
The high leucine dose in
(2012)
high intensity endurance the supplement saturated
exercise and
BCAA metabolism,
subsequently ingested
increased leucine
leucine/protein
oxidation and attenuated
supplement or control.
MPB.
AAs: Amino Acids; MPS: Muscle Protein Synthesis; EAAs: Essential Amino Acids;
BCAA: Branched Chain Amino Acid; MPB: Muscle Protein Breakdown

In these studies, performed to assess the effect of leucine supplementation and/or dietary
intake, the general consensus was that leucine intake in excess of the amount found in
adequate whole protein is unnecessary. Most studies found that leucine supplementation
in addition to protein intake saturated metabolism and leucine oxidation resulted. The
studies where leucine supplementation was seen to be additive were in conjunction with
lower protein doses, or supplementation was seen to have the same effect as complete
meals. In summary, research has shown that excessive intake of leucine in addition to
adequate protein ingestion is unnecessary to stimulate MPS.

Timing, Dosing, and Long Term Effects
Researchers have speculated on the specific intake of leucine that constitutes an adequate
dose to promote MPS. Churchward-Venne et al. (2012) reported that, leucine ingestion in
larger amounts than that found in a saturating dose (20-25g whey protein containing 2.53g leucine), would not be likely to promote a further increase in MPS magnitude or
duration. The authors cautioned that as the data were taken from young healthy men
(weighing ~86 kg), the dose of protein necessary to be maximally effective could be far
different in a ~50 kg female gymnast or a 120 kg bodybuilder.

A review by Rennie et al. (2006) similarly stated that there is little evidence that high
rates of physical activity increase protein requirements beyond those achieved by eating a
normal diet that fulfills energy requirements. They acknowledged that providing
supplemental leucine will stimulate MPS, but the effect will likely be transitory given the
“muscle-full” phenomenon. The researchers posited that amino acid administration that
mimics meal feeding would allow the muscle fullness set point to be modified to increase
anabolism. Another reason to restrain dosing to modest levels is that amino acids have
effects on protein synthesis and breakdown within a narrow range of concentration as the
daily variation in the blood is only ~ ±50 % of the daily mean (Bergstrom et al., 1990).

More recent evidence points to saturation of phosphorylation of initiation factors and, as
stated previously, decreased sensitivity of signaling as the mechanism behind leucine’s
28
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seeming decrease in efficacy. Researchers examined rat liver and skeletal muscle after
administration of leucine, ranging from 0.169 to 1.35 g/kg of body weight. In skeletal
muscle, phosphorylation reached a plateau at 0.675 g/kg of body weight. The mTOR
signaling sensitivity to leucine in the skeletal muscle appeared to be higher than that in
the liver (Yoshizawa et al., 2013).

Aside from leucine, there may be other EAAs that can stimulate MPS. Valine,
phenylalanine and threonine have each been shown to increase human MPS when given
in a flooding dose (Smith et al., 1998). While the proposed effects of mega-doses of other
EAAs may hold true, the relative efficiency of much smaller doses of leucine indicates
greater efficacy and potency.

Despite possible benefits of supplementation with leucine, some adverse effects have
been seen related to doses administered. Effects reported include reduced food intake
(Blouet et al., 2009), imbalance of other BCAAs (Allen & Baker 1972), and decreased
growth and immune response in pigs (Gatnau et al., 1995). In contrast, Nguema et al.
(2007), found no changes in food intake associated with leucine supplementation. Since
the leucine dose necessary for increased plasma leucine concentration is not
supraphysiological, it is unlikely to suppress appetite and reduce whole food intake.

The increase in blood AA concentrations postmeal lasts ~3 hours, (Bergstrom et al.,
1990) and the increased AA supply is available for up to six hours, however, MPS
appears to become unresponsive after 2.5 hours (Bohé et al., 2001). Another study
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suggested this decrease in efficacy over time is due to desensitization of the signaling
mechanism that senses and transmits information about AA availability. The authors
further stated that long-term parenteral infusions of AAs will not maintain anabolism
longer than a couple of hours and excess AAs are simply catabolized to urea. They
warned that if studies are to obtain accurate values of human MPS, they need to be
confined to periods of <3 hours, with 2.5 hours being optimal (Rennie et al., 2006).

Since studies show stimulation of MPS is time limited (Bohé et al., 2001), it appears that
only modest amounts of dietary amino acids would be needed to achieve maximal
stimulation of the muscle anabolic processes (i.e., for adults of average weight, 30–40g of
protein). The amount of protein necessary to build and maintain muscle can be easily
obtained from a normal diet which is adequate to satisfy total energy needs for the
individual since most diets contain at least 10-15% protein. Moreover, dietary protein
consumed after exercise in excess of the amount which can be incorporated into muscle
protein stimulates oxidation (Moore et al., 2009).

Recent evidence suggests that physical training increases protein metabolism efficiency,
whether moderate endurance exercise or resistance training. Endurance training does not
increase leucine oxidation and protein metabolism becomes more efficient- increased
protein balance is achieved at a lower rate of oxidation (Gaine et al., 2005).
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Table 5: Summary of studies related to timing, dosing, and long-term effects of leucine
supplementation
Reference
Population
Design
Findings
Allen & Baker Chickens
Chickens were fed
The availability of the
(1972)
varying amounts of excess other BCAAs decreased
leucine in their diets.
as excess dietary leucine
increased.
Gatnau et al.
Pigs
Pigs were supplemented
High dietary leucine
(1995)
with varying levels of
intake contributed to
dietary leucine.
poor growth and
immunity.
Smith et al.
23 young
Participants were given
Flooding doses of EAAs
(1998)
males
flooding doses of
stimulated increased
individual EAAs and non- incorporation of tracers.
EAAs.
Bohé et al.
6 humans
Mixed AAs were infused
MPS rates declined
(2001)
by IV.
rapidly after 2 hours.
Gaine et al.
7 humans
Participants consumed a
Leucine oxidation
(2005)
controlled diet and
decreased as protein
performed aerobic
utilization improved.
exercise for 4 weeks.
Diets composed of
Nguema et al.
Rats
Rats were fed long term
casein and supplemented
(2007)
diets with differing
with EAAs sustained
sources of protein.
appetite.
Increased leucine
Blouet et al.
Rats
Rats consumed a diet
(2009)
supplemented with leucine availability in
mediobasal
or a high protein diet.
hypothalamus led to
decreased food intake.
Moore et al.
6 young
Participants performed
Leucine oxidation
(2009)
males
resistance exercise then
increased after 20g
consumed differing
protein as MPS was
amounts of protein.
maximally stimulated.
Churchward24 males
Participants completed
Low doses of whey
Venne et al.
resistance exercise and
supplemented with
(2012)
consumed varying doses
leucine or EAAs
of whey supplemented
stimulated MPS to the
with leucine or EAAs
same degree as larger
without leucine.
doses.
Nelson et al.
12 males
Participants performed
Supplemental leucine
(2012)
high intensity endurance
dose saturated BCAA
exercise and subsequently metabolism, increased
ingested leucine/protein
leucine oxidation,
supplement or control.
attenuated MPB.
Yoshizawa et
Rats
Rats were supplemented
Muscle phosphorylation
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al. (2013)

with oral leucine in
plateaued at 0.675 g/kg
varying doses.
of body weight.
BCAAs: Branched Chain Amino Acids; EAAs: Essential Amino Acids; AAs: Amino
Acids; MPS: Muscle Protein Synthesis; MPB: Muscle Protein Breakdown

In the studies compiled in Table 5, performed to assess the optimal timing and dosing of
leucine supplementation and the long-term effects, the consensus was that leucine intake
in excess of that found in ~20g whole dietary protein or ~0.75mg/kg free leucine is
unnecessary. Other studies found the window to evaluate MPS post-exercise should be
contained to 2.5 hours. There was little consensus and inadequate data to postulate on the
effects of long-term leucine supplementation.

Effects After Resistance and Endurance Exercise
Do the previously seen effects of leucine supplementation on MPS after exercise have
consistent results despite varying types of exercise? Resistance exercise and training can
have a remarkable effect on body composition by increasing muscular strength and
hypertrophy. For hypertrophy to occur MPS must surpass muscle protein catabolism and
as previously stated, availability of AAs is a chief factor in promoting protein synthesis
(Norton & Layman, 2006; Rannels et al., 1974; Garlick & Grant, 1988). Significantly
lower levels of serum AAs, predominantly leucine and isoleucine, have been noted
following resistance training. Supplementing the diet with EAAs circumvents this decline
and increases AA availability to the muscles.

Studies that have examined the physiological mechanism of leucine efficacy identify
messenger RNA translation via the activation of a variety of intracellular signaling
proteins, especially those of the mTOR signaling cascade as the primary level of
regulation of acute MPS. Stimulation of MPS after food intake or exercise is
accompanied by increased phosphorylation, and activity, of the mTOR signaling pathway
(Karlsson et al., 2004; Kimball & Jefferson, 2004, 2006; Wilkinson et al., 2013; Coffey et
al., 2011).

Moore et al. (2009) examined the response of protein synthesis and total body leucine
oxidation to increasing protein intake after an acute bout of resistance exercise.
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Increasing protein intake stimulated muscle and plasma albumin protein synthesis in a
dose-dependent manner up to 20g dietary protein, after which there was a significant
stimulation of whole-body leucine oxidation and no added increase in protein synthesis.

Given that energy needs are met, the findings by Moore et al. have implications for
protein recommendations for athletes participating in resistance exercise in terms of the
quantity of dietary protein to maximize muscle growth. If a 20g protein dose maximally
stimulates MPS after exercise and resistance exercise enhances the synthesis of muscle
protein for at least 24 hours, the question becomes: How often in a day should an athlete
consume such a dose to stimulate muscle anabolism and maximize muscle growth? As
MPS becomes refractory to continual aminoacidemia and excessive AAs are lost to
oxidation, the authors speculated that 20g of high quality dietary protein could be
ingested 5–6 times and MPS could be expected to be maximally stimulated. Consumption
of protein in excess of this dose would just lead to oxidative loss. More importantly,
given that AAs oxidation capacity adapts to diet and acts as a key regulator of protein
stores, chronic excessive protein may actually lead to weakening of the protein synthetic
response to protein doses less than the optimal 20g (Moore et al., 2009).

The resistance exercise and EAA supplementation combination is an effective stimulator
of protein synthesis (Biolo et al., 1997; Preedy & Garlick, 1986). Whey protein is a rich
source of EAAs, including the BCAAs, and especially leucine. As a source of AAs, whey
has been examined for potential ergogenic effects in combination with resistance training
Burke et al., 2001). The purpose of a study by Coburn et al. (2006) was to examine the
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effects of resistance training in conjunction with a leucine (6.2g) and whey protein (20g)
supplement. Significantly greater strength increases were seen in the group consuming
the leucine and whey supplement over those consuming a carbohydrate placebo. The two
groups were not matched for protein intake, however, and these effects may be
contributed solely to the addition of protein to leucine and whey supplemented group.

In order to elucidate the efficacy of supplemental leucine and resistance exercise on
muscle anabolism, Tipton et al. (2009) investigated the response of net muscle protein
balance to ingestion of additional leucine with protein in association with resistance
exercise. Subjects performed resistance exercise following ingestion of 1 of 2 drinks:
placebo or 16.6g of whey protein + 3.4g of leucine. Whey protein plus leucine ingestion
resulted in an elevated anabolic response in muscle, but not one that is greater than the
response to whey protein alone.

Researchers surmised that since protein synthesis results not only from provision of
substrate for synthetic processes, but also from stimulation of signaling pathways in
muscle cells, bolus doses cannot further stimulate protein synthesis once the signaling
pathway thresholds are met. The anabolic pathways are likely fully stimulated by the
amino acid provision of the whey protein and/or resistance exercise, so the additional
leucine presents no further advantage (Tipton et al., 2009).

Another study sought to investigate the effects of daily oral leucine ingestion on strength,
lean tissue mass (LTM), and fat mass (FM) of subjects during a 12-week resistance-
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training program (Ispoglou et al., 2011). Participants ingested either 4g per day leucine or
a corresponding amount of lactose and trained under supervision twice per week.
Strength on each exercise was assessed by five repetition maximum, and body
composition was assessed by DEXA. The leucine group demonstrated significantly
higher strength gains, but there were no significant differences between groups in either
total percentage LTM gains or FM losses. This research suggests that 4g per day leucine
ingestion could be used as a supplement to enhance strength performance during
resistance training.

Koopman et al. (2007) also agreed that resistance exercise is a potent stimulus to
augment muscle protein anabolism, but that the intake of food during post-exercise
recovery is required for hypertrophy to take place. Interestingly, protein catabolism is
stimulated to a greater extent than protein synthesis following exercise. In consequence,
athletes need to consume sources of protein post-exercise to achieve a positive protein
balance and maximize their skeletal muscle adaptive response. For this reason,
carbohydrate and protein/AA ingestion during exercise recovery is part of an effective
strategy to stimulate MPS, inhibit protein breakdown and, as a result, augment net muscle
protein accretion.

Kirby et al. (2012) focused on leucine’s ability to attenuate muscle damage, more so than
its specific effect on MPS, but as previously discussed, muscle hypertrophy is a result of
decreased muscle breakdown as well. Kirby et al. (2012) attempted to determine the
effect of leucine supplementation on indices of muscle damage following eccentric-based
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resistance exercise. Muscle function was determined by peak force during an isometric
squat and by jump height. The leucine supplemented group experienced an attenuated
drop in mean peak force compared to the placebo group. The principal discovery was that
high-dose leucine supplementation was not able to attenuate the increase in biochemical
markers of muscle damage that follows eccentric-based resistance exercise. It may,
however, aid in maintaining isometric force output.

Although some previously mentioned studies have seen positive results by combining
leucine supplementation with carbohydrate ingestion (Dreyer et al., 2007; Coffey et al.,
2011), the following study utilized EAAs, which would theoretically further enhance
MPS. This study evaluated whether EAA and carbohydrate ingestion before resistance
exercise can improve direct measures of post-exercise MPS like fractional synthetic rate
(FSR). Researchers found that muscle FSR was enhanced in the EAA + CHO group
immediately following EAA + CHO ingestion, declined to basal values during exercise,
and remained unchanged at 1-hour post-exercise. Muscle FSR decreased in the fasting
group during exercise and increased at 1-hour post-exercise. The researchers concluded
that EAA + CHO ingestion before resistance exercise did not enhance post-exercise FSR
compared with exercise in a fasting state (Fujita et al., 2009).

The effects of endurance exercise differ from those of resistance exercise, as endurance
training generates lower muscle contractile forces and characteristically does not induce
muscle hypertrophy (Phillips et al., 1996). Sustained endurance exercise is largely
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catabolic and reduces MPS and plasma leucine concentrations during exercise due to the
metabolic demand for BCAAs in training skeletal muscle (Norton & Layman, 2006).

Provision of supplemental leucine during endurance exercise could stimulate greater
post-exercise MPS by diverting protein utilization form endogenous stores (Pasiakos et
al. 2011). In this study the effects of consuming an optimal EAA dose (consistent with
high-quality proteins) supplemented with leucine during endurance exercise on MPS,
intracellular signaling, and protein metabolism during recovery was assessed. Participants
completed 2 bouts of cycle ergometry, and one of two isonitrogenous drinks with
differing leucine contents [leucine+EAA, 3.5g leucine; EAA, 1.87g leucine] was
consumed during exercise. MPS and protein turnover were determined by continuous
tracer infusions. This trial found the supplement enhanced post-exercise MPS by 33%
when compared with a control. These findings signify that increasing leucine content in
an already optimal EAA dose results in further MPS increases following endurance
exercise. Additional leucine availability may have spared endogenous protein stores to a
greater extent than EAA alone, however, the EAA supplement plus leucine concentration
did not improve mTORC1 intracellular signaling (Pasiakos et al., 2011).

Thomson et al. (2011) attempted to establish how consuming leucine-rich protein and
high carbohydrate post-exercise would affect recovery, as measured by subsequent
cycling and mechanistic markers. Cyclists performed 2- to 2.5-hour interval training
bouts, then ingesting leucine-enriched protein (0.1 & 0.4g/kg/hr), high carbohydrate
(1.2g/kg/hr) nutrition or isocaloric control nutrition. Post-exercise leucine ingestion
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improved mean sprint power by 2.5% and a reduction in creatine kinase (CK) activity
was suggestive of attenuated disruption to skeletal muscle integrity and faster muscle
repair. The findings are relevant to real life practice as the supplement was provided
along with regular food items, ingested following exercise in a realistic time frame, and
provided with an appropriate quantity of carbohydrate to optimize glycogen repletion
(Thomson et al., 2011).

While not directly researching leucine and MPS, a study by Greer et al. (2007) found
BCAA ingestion prior to and during endurance exercise attenuated indices of muscle
damage, which may have a limited effect on physical performance. Participants ingested
a carbohydrate or BCAA beverage before, during, and after a 90 minute cycling bout.
Lactate dehydrogenase (LDH) and CK measures of muscle damage were lower in the
BCAA-supplemented group compared to placebo and carbohydrate groups, and legflexion torque was higher at the 48-hour mark, possibly due to decreased muscle damage.
If this exercise-induced muscle damage can be reduced by supplementation, then
logically speaking, subsequent performance should improve or be maintained.

One more study (Nelson et al., 2012) looking at leucine’s effects following endurance
exercise used a leucine plus carbohydrate, fat, and protein supplement (7.5/20/89/22
g/hour, respectively) and an isocaloric fat and carbohydrate control. Subjects ingested
one of the supplements following high-intensity cycling and researchers measured repeat
performance and muscle indices of damage and turnover. The leucine supplemented
group saw greater plasma BCAA levels and leucine oxidation indicating the 10g leucine
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dosage exceeded BCAA metabolism capacity. CK levels were lower in the experimental
group, but the apparent effect on subsequent performance was “trivial” per the study
authors.

Table 6: Summary of studies related to effect of leucine supplementation on resistance
versus endurance exercise
Reference
Population
Design
Findings
Karlsson et
7 males; age
Participants consumed a
BCAA ingestion
al. (2004)
25 ± 1 yr
BCAA or placebo before
increased
and after performing
phosphorylation of
resistance exercise.
signaling proteins in
skeletal muscle.
Coburn et al. 33 males; age Participants consumed a
The supplement group
(2006)
24.4 ± 2.4 yrs leucine/whey or control
saw greater strength
supplement and performed increases.
resistance exercise.
Dreyer et al. 16 young
Participants consumed an
Enhanced mTOR
(2007)
males
EAA+CHO or control
signaling and FSR were
supplement 1 hour after
seen in the EAA+CHO
resistance exercise.
group.
Greer et al.
9 males; age
Participants consumed
BCAA supplementation
(2007)
21.6 ± 3.2 yrs BCAA, CHO, or placebo
attenuated CK and LDH
beverage before and during concentrations.
endurance cycling.
Koopman et
8 elderly
Participants consumed a
Whole body protein
al. (2008)
males; age 73 supplement with leucine or balance was greater in
± 1 yr
a control 30 min after
the leucine group, but
resistance exercise.
FSR was not affected.
Moore et al.
6 males; age
Participants consumed
MPS displayed a dose
(2009)
22 ± 2 yrs
differing doses of whole
response to protein
egg protein after resistance ingestion and was
exercise.
maximally stimulated at
20g.
Tipton et al.
15 humans
Participants performed
Leucine stimulated MPS
(2009)
resistance exercise after
to a greater extent than
consuming placebo or
placebo.
leucine supplement
Fujita et al.
22 humans
Participants either fasted or EAA+CHO did not
(2009)
consumed EAA+ CHO
increase FSR
prior to performing
postexercise compared
resistance exercise.
to fasting.
Coffey et al. 8 males; age
Participants performed
MPS and anabolic
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(2011)

Ispoglou et
al. (2011)

Pasiakos et
al. (2011)

Thomson et
al. (2011)

21.4 ± 2.6 yrs

sprint cycling after
consuming either
whey+leucine+CHO or
placebo.
26 males
Participants consumed
either leucine or lactose
daily for 12 wks and
performed resistance
exercise 2x/wk.
8 humans; age Participants consumed
24 ± 2 yrs
either a low-leucine or
high-leucine EAA
supplement during
endurance exercise.
10 males
Participants performed
cyclists
endurance cycling and
consumed leucine-enriched
supplement or isocaloric
control post-exercise.

signaling was greater
following the
whey+leucine+CHO
provision.
The leucine group had
greater strength gains,
but not LTM or FM
losses.
The leucine-enriched
supplement induced
greater MPS, less MPB,
and greater oxidation.

Post-exercise leucine
ingestion improved
sprint power and
reduced perceived
overall tiredness during
sprints.
Howatson et 12 males; age Participants consumed a
BCAA supplementation
al. (2012)
23 ± 2 yrs
BCAA supplement or
reduced indices of
placebo and performed
muscle damage and
drop jumps.
improved recovery time.
Kirby et al.
27 males; age Participants consumed
The leucine group had
(2012)
21.3 ± 1.6 yrs leucine or placebo before,
an attenuated drop in
during, after performing
mean peak force
depth jumps.
compared to placebo.
Nelson et al. 12 male
Participants consumed a
Leucine ingestion
(2012)
cyclists
leucine-enriched
increased BCAA
supplement or isocaloric
oxidation, decreased CK
control after endurance
concentration, and had
exercise.
trivial effect on sprint
power.
BCAA: Branched Chain Amino Acid; EAA: Essential Amino Acid; CHO:
Carbohydrate; mTOR: Mammalian Target of Rapamycin; FSR: Fractional Synthetic
Rate; CK: Creatine Kinase; LDH: Lactate Dehydrogenase; MPS: Muscle Protein
Synthesis; LTM: Lean tissue mass; FM: Fat mass; MPB: Muscle Protein Breakdown

These studies, compiled in Table 6, performed to assess the effect of leucine
supplementation on resistance or endurance exercise, found supplementation in addition
to exercise increased MPS in conjunction with resistance exercise and attenuated MPB in
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conjunction with endurance exercise. The two studies (Fujita et al. 2009; Koopman et al.
2008) in which leucine supplementation was not seen to have a greater effect than the
control had no similar characteristics from which to draw conclusions as to the type of
situation where leucine may be most effective. In summary, the studies shown in Table 6
indicated leucine may improve subsequent performance in relation to both resistance and
endurance exercises.

Conclusion
Leucine has been shown throughout numerous studies over the last 30+ years to be an
effective stimulator of MPS in varied populations and in different training scenarios
(Buse & Reid, 1975; Casperson et al., 2012; Coburn et al., 2006; Dreyer, 2008; Katsanos
et al., 2006; Pasiakos et al., 2011). This essential amino acid has been established as a
potent regulator of metabolism, a signal in the mTOR transduction pathway, and of key
importance in its ability to help spare endogenous protein stores (Alvestrand et al., 1990;
Balage et al., 2011; Drummond & Rasmussen, 2008; Garlick, 2005; Kimball & Jefferson,
2004; Louard et al., 1990). Many studies mentioned previously examined its role in
protein metabolism and identified leucine as the most effective amino acid in activating
MPS, preventing muscle breakdown, and maintaining positive net muscle protein.
Leucine’s efficacy is not clear cut however, as there are many qualifications to consider.

Some may assume since leucine is ingested on a daily basis and is found in many
common foods, its isolated consumption would be beneficial and harbor no dangers.
However, intake of isolated amino acids often leads to imbalances in these nutrients and
can instigate deleterious effects in vivo. Normally, amino acids are consumed as a part of
an entire meal, and that intake is accompanied by a resultant rise in blood glucose and
insulin release, which have been found to facilitate leucine’s mechanism of action
(Preedy & Garlick, 1986; Garlick & Grant, 1988; Li et al., 2013). This may be due to an
43

44
increase in the insulin sensitivity in cells post-meal caused by amino acid consumption.
Researchers have surmised that as protein synthesis results not only from availability of
substrates for synthetic processes, but also from activation of signaling pathways in cells,
bolus doses cannot further increase protein synthesis once the signaling pathway
thresholds are met (Drummond & Rasmussen, 2008). Bolus dosing of any amino acid, in
particular leucine, could potentially lead to insulin resistance due to prolonged
stimulation of the insulin response (Li et al., 2013). Also, as cells’ amino acids oxidation
capacity adapts to dietary intake, chronic excessive intake could lead to blunting of the
protein synthetic response to protein doses less than bolus intakes.

Provided that total body energy requirements are met, leucine supplementation has a dose
dependent protein synthesis response, a greater activation of synthetic signaling
pathways, as well as the ability to spare body protein stores. MPS is stimulated
immediately following intake while the amino acid pool is elevated, so studies have seen
greater effects on muscle hypertrophy when leucine is consumed post-exercise than when
it is consumed prior to activity. This is also because leucine appears to be more effective
in stimulating MPS when muscle is in an anabolic state, as it is post-exercise (Anthony et
al., 1999; Dreyer et al., 2008).

Following either resistance or endurance exercise, leucine has been shown to be effective
in stimulating muscle protein synthesis. It has been seen to be more effective as a postexercise supplement than water, an isocaloric carbohydrate supplement, lactose, an
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isonitrogenous EAA supplement, or fasting (Churchward-Venne et al., 2012; Dreyer et
al., 2008; Stock et al., 2010; Ispoglou et al., 2011).

While hundreds of studies have been performed on leucine in various situations, a couple
holes in the literature may still exist. To prevent some of the poor outcomes discussed
here, an upper limit of leucine intake should be established or, preferably, a widely
accepted recommendation for appropriate doses of high-quality protein as leucine is more
effective when consumed as part of meal. The long-term effects of chronic leucine
supplementation would be a study worth noting as well. An investigation into the effects
of leucine intake prior to and following exercise may find a consistently elevated amino
acid pool and continued FSR maintenance.

In conclusion, adding high leucine foods, including whey, eggs, poultry, fish, and kidney
beans, to meals during post-exercise recovery may aid in increasing muscle hypertrophy,
attenuating muscle breakdown, and maintaining net positive muscle protein. Some
studies have found that bolus doses of leucine are not more effective than doses that
could be ingested from a healthy diet, and may induce detrimental health effects,
including insulin resistance (Zanchi et al., 2012; McCormack et al., 2013). Others have
found that increasing dietary leucine has a positive effect on insulin sensitivity (Li et al.,
2013; Zhang et al., 2012). Despite the lingering questions regarding a potentially
negative health impact with high dose intakes, consumption of high leucine foods and
leucine-enhanced foods and supplements (e.g., whey protein food bars) post-exercise
have been found to enhance muscle protein synthesis.
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